在肺癌中TRPA1的作用
Diarmuid O'Connor1,2, Stephen P Finn1,3, Steven G Gray1,2
1Thoracic Oncology Research Group, Central Pathology Laboratory, St. James's Hospital, Dublin, Ireland.
Translational lung cancer research
|November 14, 2025
概括
过渡性受体潜在安基林-1 (TRPA1) 与肺癌进展和转移有关. 向TRPA1可能为肺癌患者的癌症治疗和疼痛管理提供新的策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 肺癌仍然是全球癌症死亡的主要原因,非小细胞肺癌 (NSCLC) 占病例的85%.
- 耐药性和诊断的晚期阶段在NSCLC管理中存在重大挑战.
- 一种离子通道,即暂时受体潜能安基林-1 (TRPA1),因其在炎症中的作用而闻名,并与各种癌症有关.
研究的目的:
- 审查目前对TRPA1在肺中的生物功能的理解.
- 总结针对TRPA的现有治疗策略1.
- 探索TRPA1作为肺癌和疼痛管理治疗点的潜力.
主要方法:
- 在基研究表明TRPA1mRNA在NSCLC上调,与晚期和转移相关.
- 关于TRPA1在其他癌症和炎症性肺病中的作用的现有文献综述.
- 对针对TRPA的潜在治疗干预措施的分析1.1.
主要成果:
- 在非小细胞肺癌 (NSCLC),特别是肺腺癌 (LUAD) 和肺状细胞癌 (SCC) 中,TRPA1的表达上调.
- TRPA1上调与增加的肺癌阶段和转移风险正相关.
- 证据表明TRPA1参与了小细胞肺癌 (SCLC) 和NSCLC的发病,尽管它在LUAD中的作用需要进一步调查.
结论:
- TRPA1在肺癌的发展和进展中起着重要作用,特别是在NSCLC中.
- 向TRPA1为新型抗癌疗法提供了一个有希望的途径.
- 调节TRPA1也可能有利于肺癌患者的疼痛管理.
相关概念视频
lncRNA - Long Non-coding RNAs
9.7K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.7K
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
The Ras Gene
7.0K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
7.0K
Enzyme-linked Receptors
85.7K
Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
85.7K
Abnormal Proliferation
5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
MAPK Signaling Cascades
7.8K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.8K

